Moderna Inc
- All
- News
- Videos
-
US Backs Moderna, Says Government Should Face Covid Vaccine Lawsuit
The USgovernment should face a patent lawsuit over COVID-19 vaccines, not vaccine maker Moderna Inc, the Department of Justice told a Delaware federal court on Tuesday.
-
Moderna Recalls Thousands Of Covid Doses In Europe. Here's Why
Moderna Inc said on Friday it was recalling 764,900 doses of its COVID-19 vaccine made by its contract manufacturer Rovi after a vial was found contaminated by a foreign body.
-
Oil Prices Plunge As Omicron's Rapid Spread Dims Fuel Demand Outlook
Oil prices fell despite Moderna Inc's announcement on Monday that a booster dose of its COVID-19 vaccine appeared to be protective against Omicron in laboratory testing.
-
Japan Approves Moderna Covid Booster Shots Aiming To Increase Coverage
Japan on Thursday officially approved Moderna Inc's COVID-19 vaccine for its booster programme, while Novavax Inc filed for first approval of its shot in the country.
-
Moderna Shot Could Start Being Used In Children, Teens Within Weeks: CEO
Moderna Inc's COVID-19 vaccine could start to be used in children and teens in the United States within weeks, its chief executive said in an interview ahead of the Reuters Total Health conference, which will run virtually from Nov. 15-18.
-
Moderna Says Its Covid Vaccine Protective, Safe In Young Children
Moderna Inc said on Monday its COVID-19 vaccine generated a strong immune response and was generally well-tolerated in children aged six to 11 years, citing interim data from a study.
-
Another Moderna Vial With Suspected Foreign Substance Found In Japan
Japan's Kanagawa prefecture said it has found another vial of Moderna Inc's COVID-19 vaccine suspected of containing a foreign substance and has put the rest of the lot on hold.
-
Japan Withdraws 1 Million More Moderna Shots As Foreign Substances Found
Moderna Inc's COVID-19 vaccine contamination problems in Japan have widened with another million doses being suspended, after foreign substances were found in more batches and two people died following shots from affected lots.
-
Moderna Says COVID-19 Shot 93% Effective 6 Months After Second Dose
Moderna Inc said on Thursday its COVID-19 shot was about 93% effective through six months after the second dose, showing hardly any change from the 94% efficacy reported in its original clinical trial.
-
Moderna Says Its Covid Shot Produces Antibodies Against Delta Variant
Moderna Inc. said its vaccine produced protective antibodies against the delta variant spreading in the U.S. and many other parts of the world.
-
Moderna Says To Produce Up to 3 Billion Covid Vaccine Doses In 2022
Moderna Inc said on Thursday it is boosting manufacturing capacity for its COVID-19 vaccine and expects to make up to 3 billion doses in 2022, more than twice its previous forecast.
-
Protection From Our COVID-19 Vaccine Still Strong Six Months On: Moderna
Moderna Inc said on Tuesday that its COVID-19 vaccine still showed strong protection against the illness six months after people received their second shot.
-
US Begins Study On Allergic Reaction Risk In Moderna, Pfizer Vaccines
The US National Institutes of Health said on Wednesday it had begun a mid-stage study to determine the risk of allergic reactions to COVID-19 vaccines made by Moderna Inc and Pfizer Inc.
-
Pfizer, Moderna Vaccines Highly Effective Even After 1st Shot: US Study
COVID-19 vaccines developed by Pfizer Inc with BioNTech SE and Moderna Inc reduced the risk of infection by 80 per cent two weeks or more after the first of two shots, according to data from a real-world study of vaccinated US healthcare personnel and first responders released on Monday.
-
Moderna Begins Testing Next-Generation Covid Vaccine
Moderna Inc said on Monday it had dosed the first participant in an early-stage study of a new COVID-19 vaccine candidate that could potentially be stored and shipped in refrigerators instead of freezers.
-
US Backs Moderna, Says Government Should Face Covid Vaccine Lawsuit
The USgovernment should face a patent lawsuit over COVID-19 vaccines, not vaccine maker Moderna Inc, the Department of Justice told a Delaware federal court on Tuesday.
-
Moderna Recalls Thousands Of Covid Doses In Europe. Here's Why
Moderna Inc said on Friday it was recalling 764,900 doses of its COVID-19 vaccine made by its contract manufacturer Rovi after a vial was found contaminated by a foreign body.
-
Oil Prices Plunge As Omicron's Rapid Spread Dims Fuel Demand Outlook
Oil prices fell despite Moderna Inc's announcement on Monday that a booster dose of its COVID-19 vaccine appeared to be protective against Omicron in laboratory testing.
-
Japan Approves Moderna Covid Booster Shots Aiming To Increase Coverage
Japan on Thursday officially approved Moderna Inc's COVID-19 vaccine for its booster programme, while Novavax Inc filed for first approval of its shot in the country.
-
Moderna Shot Could Start Being Used In Children, Teens Within Weeks: CEO
Moderna Inc's COVID-19 vaccine could start to be used in children and teens in the United States within weeks, its chief executive said in an interview ahead of the Reuters Total Health conference, which will run virtually from Nov. 15-18.
-
Moderna Says Its Covid Vaccine Protective, Safe In Young Children
Moderna Inc said on Monday its COVID-19 vaccine generated a strong immune response and was generally well-tolerated in children aged six to 11 years, citing interim data from a study.
-
Another Moderna Vial With Suspected Foreign Substance Found In Japan
Japan's Kanagawa prefecture said it has found another vial of Moderna Inc's COVID-19 vaccine suspected of containing a foreign substance and has put the rest of the lot on hold.
-
Japan Withdraws 1 Million More Moderna Shots As Foreign Substances Found
Moderna Inc's COVID-19 vaccine contamination problems in Japan have widened with another million doses being suspended, after foreign substances were found in more batches and two people died following shots from affected lots.
-
Moderna Says COVID-19 Shot 93% Effective 6 Months After Second Dose
Moderna Inc said on Thursday its COVID-19 shot was about 93% effective through six months after the second dose, showing hardly any change from the 94% efficacy reported in its original clinical trial.
-
Moderna Says Its Covid Shot Produces Antibodies Against Delta Variant
Moderna Inc. said its vaccine produced protective antibodies against the delta variant spreading in the U.S. and many other parts of the world.
-
Moderna Says To Produce Up to 3 Billion Covid Vaccine Doses In 2022
Moderna Inc said on Thursday it is boosting manufacturing capacity for its COVID-19 vaccine and expects to make up to 3 billion doses in 2022, more than twice its previous forecast.
-
Protection From Our COVID-19 Vaccine Still Strong Six Months On: Moderna
Moderna Inc said on Tuesday that its COVID-19 vaccine still showed strong protection against the illness six months after people received their second shot.
-
US Begins Study On Allergic Reaction Risk In Moderna, Pfizer Vaccines
The US National Institutes of Health said on Wednesday it had begun a mid-stage study to determine the risk of allergic reactions to COVID-19 vaccines made by Moderna Inc and Pfizer Inc.
-
Pfizer, Moderna Vaccines Highly Effective Even After 1st Shot: US Study
COVID-19 vaccines developed by Pfizer Inc with BioNTech SE and Moderna Inc reduced the risk of infection by 80 per cent two weeks or more after the first of two shots, according to data from a real-world study of vaccinated US healthcare personnel and first responders released on Monday.
-
Moderna Begins Testing Next-Generation Covid Vaccine
Moderna Inc said on Monday it had dosed the first participant in an early-stage study of a new COVID-19 vaccine candidate that could potentially be stored and shipped in refrigerators instead of freezers.
